Skip to content
Sign in
AcceleratorBacked 1 network startup

Gust Accelerator

US accelerator with no public profile in our data; supported maternal-health medtech Lidavex.

United States
Ticket
—Not published
Assets under management
—
Founded
—
Stages
—
Network startups backed
1
Co-investors
1most often with Octane LaunchPad

How they invest

Unknown — no description or thesis. One support relationship with Lidavex (obstetric monitoring).

Stage and ticket

Unknown; accelerator/support programme.

Geography

United States (HQ).

What makes them say yes

  • Early US medtech (inferred from Lidavex)
  • Accelerator-ready team
  • Co-support with Octane LaunchPad

Red flags

  • No published thesis, ticket or stage policy in our data — any approach is a cold qualification call
  • Pitching outside the single sector signal visible in its known deal

Sectors

Not published

Stages

Not published

Geographies

Not published

How to approach

Ask Lidavex's founders about the programme and application route.

Portfolio

1 network startup · no other company

Single support relationship in maternal health, shared with Octane LaunchPad.

Gaps in the portfolio

  • Unknown thesis

Network startups

  • LidavexSWC 2026 Finalist

    Maternal-health device start-up using LiDAR to measure cervical dilation in labour and build a cervical data infrastructure for AI.

    United States · MedTech & devices

    • Accelerators / support programsSource

Network startups that fit

3 analysed

Nurse-practitioner-founded device start-up designing a multi-drug emergency IV pump with protocol-guided dosing safeguards.

US pre-seed emergency IV pump — early medtech like Lidavex.

30%confidence

Evidence from the records

  • “Lidavex”
  • “Multi-drug emergency IV pump”
  • “No public evidence of traction found: pump shown as a concept visual”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Gust Accelerator).
First step
Ask Lidavex for programme details.

Physician-led Kansas medtech developing UniPen, a universal vial-compatible self-injection pen aimed at cutting pharma device costs and lead times.

US pre-seed self-injection devices — early medtech.

25%confidence

Evidence from the records

  • “Lidavex”
  • “Self-injection devices”
  • “UniPen available through licensed pharmacies (not FDA-authorized)”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Gust Accelerator).
First step
Ask Lidavex for programme details.

Smartphone eyelid-photo AI that screens for anemia in seconds without a blood draw, aimed at low-resource care.

US pre-seed AI anemia screening — relevant to maternal health populations.

25%confidence

Evidence from the records

  • “Lidavex”
  • “AI anemia detection”
  • “NiADA app (analysis of a smartphone photo of the lower eyelid) available on Google Play and Apple TestFlight”
Intro path
Founder-to-founder intro via Lidavex (network portfolio company of Gust Accelerator).
First step
Low priority.

Analyst reading of 21 Nov 2026, from the public record of the network. Method: analyst-ai.

Co-investors

Most often with Octane LaunchPad

Sources

  1. 1pitchbook.com/profiles/company/600846-40

Profile compiled from public sources. Unknown fields are left empty rather than estimated.